Grošelj, Urh https://orcid.org/0000-0002-5246-9869
Kavčič, Marko https://orcid.org/0000-0002-4949-1344
Drole Torkar, Ana https://orcid.org/0000-0002-0506-2919
Kafol, Jan https://orcid.org/0009-0003-4159-1783
Lainšček, Duško https://orcid.org/0000-0001-9613-5441
Jerala, Roman https://orcid.org/0000-0002-6337-5251
Sever, Matjaž
Zver, Samo https://orcid.org/0000-0003-2932-7923
Serša, Gregor https://orcid.org/0000-0002-7641-5670
Čemažar, Maja https://orcid.org/0000-0002-1418-1928
Strojan, Primož https://orcid.org/0000-0002-0445-112X
Grošelj, Aleš
Žerjav Tanšek, Mojca https://orcid.org/0000-0002-3304-5120
Miroševič, Špela https://orcid.org/0000-0001-5004-0607
Ivančan, Simona
Prelog, Tomaž
Gosar, David
Oražem Mrak, Jasna
Mlinarič, Matej https://orcid.org/0000-0003-1143-2880
Bertok, Sara
Kovač, Jernej https://orcid.org/0000-0003-3080-4838
Kodrič, Jana
Battelino, Saba https://orcid.org/0000-0003-1478-0573
Pokorn, Marko https://orcid.org/0000-0002-2341-2791
Ihan, Alojz https://orcid.org/0000-0003-2904-1212
Jazbec, Janez https://orcid.org/0000-0002-7426-1591
Battelino, Tadej https://orcid.org/0000-0002-0273-4732
Osredkar, Damjan https://orcid.org/0000-0002-2188-420X
Funding for this research was provided by:
Javna Agencija za Raziskovalno Dejavnost RS (P3-0343, P3-0003, J7-4640, J7-4537, J3-4526, J4-4563, L3-50111)
Research Executive Agency (101059842)
Ministrstvo za visoko šolstvo, znanost in tehnologijo (3330-18-1115)
Article History
Received: 17 May 2024
Accepted: 22 May 2025
First Online: 5 June 2025
Declarations
:
: Not applicable.
: Not applicable.
: J. Kodrič received compensation for consulting services provided to Abeona Therapeutics (Ohio, United States of America) which was acquired by Ultragenyx (California, United States of America) in 2021. Other authors declare that they have no competing interests.